MERCK KGAA SPON ADR EACH REPR 0 (MKKGY) Financials
MKKGY Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
March 31, 2024 | 53.4 billion | 23.1 billion |
Dec. 31, 2023 | 54.3 billion | 24.7 billion |
Sept. 30, 2023 | 52.8 billion | 22.9 billion |
June 30, 2023 | 53.0 billion | 23.9 billion |
MKKGY Free Cash Flow and Stock based compensation
Date | Free Cash Flow | Stock based compensation |
---|---|---|
March 31, 2024 | 69.1 million | ? |
Dec. 31, 2023 | 746.2 million | 2.2 million |
Sept. 30, 2023 | 839.5 million | ? |
June 30, 2023 | 320.8 million | ? |
MKKGY Net Income
Date | Net Income |
---|---|
March 31, 2024 | 749.0 million |
Dec. 31, 2023 | 647.8 million |
Sept. 30, 2023 | 783.4 million |
June 30, 2023 | 767.7 million |
MKKGY Cash and Debt
Date | Cash | Debt | Capital Lease |
---|---|---|---|
March 31, 2024 | 2.4 billion | - | - |
Dec. 31, 2023 | 2.4 billion | - | 569.3 million |
Sept. 30, 2023 | 2.7 billion | - | - |
June 30, 2023 | 2.1 billion | - | - |
MKKGY Shares Outstanding
MKKGY Expenses
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
March 31, 2024 | 1.0 billion | 627.0 million | 358.3 million | 1.2 billion |
Dec. 31, 2023 | 417.9 million | 736.2 million | 416.8 million | 620.2 million |
Sept. 30, 2023 | 489.1 million | 615.1 million | 330.3 million | 1.2 billion |
June 30, 2023 | 355.6 million | 652.4 million | 375.1 million | 1.2 billion |
MKKGY Cost of Revenue
Date | Revenue | Cost of Revenue |
---|---|---|
March 31, 2024 | 5.5 billion | 2.3 billion |
Dec. 31, 2023 | 5.8 billion | 2.6 billion |
Sept. 30, 2023 | 5.5 billion | 2.3 billion |
June 30, 2023 | 5.8 billion | 2.3 billion |
MKKGY
Price: $36.73
Dividend Yield: 1.27%
Forward Dividend Yield: 1.29%
Payout Ratio: 34.03%
Dividend Per Share: 0.47 USD
Earnings Per Share: 1.35 USD
P/E Ratio: 27.15
Exchange: PNK
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Market Capitalization: 81.0 billion
Average Dividend Frequency: 1
Years Paying Dividends: 17
DGR3: 15.21%